TherapeuticsMD, Inc.
TXMDNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $22.47M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.03$2.95
- Volume (live)
- -
- Avg. volume (3M)
- 17.82K
TherapeuticsMD (TXMD) Stock Price & Financial Analysis
TherapeuticsMD Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.88 - $1.95 |
|---|---|
| 52-Week High | $2.95 |
| 52-Week Low | $1.03 |
| Open | $1.93 |
| Volume (last close) | 32.79K |
| Average Volume (3M) | 17.82K |
| Revenue (TTM) | 3.27M |
|---|---|
| Net Income (TTM) | -217.00K |
| Free Cash Flow (TTM) | 3.13M |
| EPS (TTM) | −$0.02 |
| Profit Margin | -6.64% |
| Operating Margin | -117.80% |
| Return on Equity (ROE) | -0.80% |
| Debt to Equity | 0.20 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | Jun 10, 2008 |
| Market Cap | 22.47M |
|---|---|
| Shares Outstanding | 11.64M |
| Price to Sales (P/S) | 6.87 |
| Price to Book (P/B) | 0.83 |
| EV/EBITDA | -4.82 |
| 50-Day MA | $2.10 |
|---|---|
| 200-Day MA | $2.12 |
| 1-Year Change | +54.40% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
TherapeuticsMD at a Glance
As of the Oct 16, 2026 close, TherapeuticsMD (TXMD) has a market capitalization of $22.47M. The stock trades at 6.9× sales. Over the trailing twelve months it lost $217.00K on revenue of $3.27M and generated $3.13M of free cash flow. Revenue grew 27.8% year over year.
As of its latest reported balance sheet, it holds $9.19M in cash and securities against $5.56M of debt, a net cash position of $3.63M.
TherapeuticsMD does not currently pay a dividend.
The share price is up 54.4% over the past year. At $1.90 (the Oct 16, 2026 close) it sits within its 52-week range of $1.03 to $2.95, below its 200-day moving average of $2.12.
Frequently Asked Questions About TherapeuticsMD
What is the current stock price for TXMD?
As of the Oct 16, 2026 close, TXMD stock trades at $1.90. The 52-week range is $1.03–$2.95, with a day range of $1.88–$1.95.
What is the P/E ratio for TXMD?
The P/E ratio (Price-to-Earnings) for TXMD is shown in the Key Statistics section. This valuation metric helps compare TherapeuticsMD, Inc. to industry peers.
Does TXMD pay dividends?
TherapeuticsMD does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TXMD?
Analyst ratings and recommendations for TXMD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TXMD?
As of the Oct 16, 2026 close, TherapeuticsMD's market capitalization is $22.1M, classifying it as a micro-cap company. TherapeuticsMD operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.